Jeff Eidel's most recent trade in Pacific Biosciences of California Inc was a trade of 26,760 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Aug. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of California Inc | Jeff Eidel | See Remarks | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 19 Aug 2024 | 26,760 | 869,730 (0%) | 0% | 1.6 | 42,602 | Common Stock |
| Pacific Biosciences of California Inc | Jeff Eidel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 461,538 | 893,362 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of California Inc | Jeff Eidel | See Remarks | Sale of securities on an exchange or to another person at price $ 5.96 per share. | 16 Feb 2024 | 15,498 | 431,824 (0%) | 0% | 6.0 | 92,337 | Common Stock |
| Pacific Biosciences of California Inc | Jeff Eidel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 164,200 | 470,602 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of California Inc | Jeff Eidel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 600,000 | 600,000 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | Jeff Eidel | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 300,000 | 300,570 (0%) | 0% | 0 | Common Stock |